← Back to patent-cliff list
BEN-2293
Tier C — Watch / tradeBEN-2293
Benevolentai Bio Ltd
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Trk-A
Indications (approved)：Atopic dermatitis
Regional status
US
-
EU
Phase II
2020-10-14
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of BEN-2293?
Approved indications include: Atopic dermatitis.
When does the BEN-2293 patent expire?
No public expiry year is available for BEN-2293 yet; this page updates once verified.
How do I get a quote for BEN-2293 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-06